Immunome announces $200 million stock offering By Investing.com
© Reuters. BOTHELL, Wash. - Immunome, Inc. (NASDAQ:IMNM), a biotechnology firm focusing on cancer therapies, has unveiled plans for a ...
Sunday, December 15, 2024
Tag: Immunome
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.